HomeNRXP • NASDAQ
Follow
NRX Pharmaceuticals Inc
Previous close
$0.52
Day range
$0.51 - $0.55
Year range
$0.22 - $1.20
Market cap
48.61M USD
Avg Volume
2.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.81M | -36.46% |
Net income | -6.06M | 33.26% |
Net profit margin | — | — |
Earnings per share | -0.07 | 50.00% |
EBITDA | -5.81M | 36.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.90M | -51.22% |
Total assets | 13.11M | -47.19% |
Total liabilities | 19.33M | 140.33% |
Total equity | -6.22M | — |
Shares outstanding | 83.25M | — |
Price to book | -7.37 | — |
Return on assets | -88.22% | — |
Return on capital | -211.42% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -6.06M | 33.26% |
Cash from operations | -4.56M | 27.16% |
Cash from investing | -2.00K | 60.00% |
Cash from financing | -1.50M | -5,260.71% |
Net change in cash | -6.07M | 3.68% |
Free cash flow | -3.34M | -15.09% |
About
Founded
2015
Headquarters
Website
Employees
2